Introduction {#sec1}
============

Musculoskeletal system tumors are rare, and these tumors must be kept in mind in differential diagnosis in patients with suspected and persistent symptoms.[@bib1] The algorithm should always follow the pattern of medical history, physical examination, radiological investigations, systemic screening, and histopathological diagnosis.[@bib1], [@bib2]

The distribution of musculoskeletal system tumors may show regional variations. In history and physical examination; understanding the region specific age, gender, localization and incidence of tumors is helpful for the diagnosis.

In this study, approximately 11,5-year data of the orthopedics and traumatology of our hospital which is a tertiary center delivering healthcare service to patients who are referred from different provinces of Turkey, and especially from central Anatolia and eastern of Turkey were analyzed. In addition, a brief literature screening was carried out on the studies conducted about incidence and distribution of bone and soft tissue localized tumors in Turkey.

Patients & methods {#sec4}
==================

This study includes data from January 2002, the time since electronic archive system available, to July 2013. Pathological outcomes of our orthopedics and traumatology clinic were obtained from the hospital registry database. Therefore, these data do not include patients with only radiological diagnosis. All patients\' age, gender, date of operation, tumor localization and tumor size were analyzed. Patients were first divided into two groups as tumoral diseases and non-tumoral causes. Tumoral diseases were then further divided as primary tumors and metastatic tumors. The primary tumors were classified and examined in separate groups according to localization in bones and soft tissues, and benign and malignant status.

All different tumors and non-tumoral causes were tabulated and figured according to the incidence, localization and age ranges ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"}, [Table 10](#tbl10){ref-type="table"} and [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}).Table 1Benign bone tumors.Table 1NumberPercentageAneurysmal bone cyst589.0Benign fibrous histiocytoma50.7Bizarre parosteal osteochondomatous proliferation10.1Bone island10.1Chondroblastoma304.6Chondromyxoid fibroma71.0Desmoid tumor (bone)30.4Enchondroma9615.0Eosinophilic granuloma132.0Fibroma (bone)20.3Fibrous dysplasia497.6Giant cell tumor (bone)7411.5Hemangioendotelyoma20.3Haemangiopericytoma10.1Intraosseous ganglion40.6Intraosseous hemangioma40.6Intraosseous lipoma81.2Non-ossifying fibroma304.6Osteoblastoma40.6Osteoid osteoma264.0Osteochondroma13020.3Periosteal chondroma10.1Schwannoma (bone)10.1Simple bone cyst9014.0Table 2Malignant bone tumors.Table 2NumberPercentageAdamantinoma20.3Angiosarcoma (bone)40.7Chondrosarcoma7714.3Chordoma71.3Epithelioid sarcoma20.3Ewing\'s sarcoma8916.5Fibrosarcoma20.3Leiomyosarcoma (bone)61.1Lymphoma203.7Leukemia30.5Malignant giant cell tumor20.3Malignant mesenchymal tumor224.0Osteosarcoma24144.7Parachordoma10.1Plasmacytoma/multiple myeloma499.1Pleomorphic sarcoma112.0Table 3Benign soft tissue tumors.Table 3NumberPercentageArterio-venous malformation40.6Baker\'s cyst60.9Benign fibrous histiocytoma20.3Calcinosis10.1Chondromyxoid fibroma (soft tissue)10.1Desmoid tumor111.7Elastofibroma dorsi20.3Epidermal inclusion cyst223.4Fibroma142.2Ganglion cyst10716.9Giant cell tumor (soft tissue)7111.2Glomus tumor30.4Hamartoma20.3Hemangioendotelyoma10.1Hemangioma10316.2Hemangiopericytoma40.6Inflammatory myofibroblastic tumor20.3Leiomyoma10.1Lymphangioma60.9Lipom14122.3Myxoid tumor10.1Myoma10.1Myxoma101.5Neurofibroma121.8Neuroma30.4Ossification fibromyxoid tumor10.1Palmar/plantar fibromatosis40.6Papilloma20.3Pilomatricoma40.6Pyogenic granuloma10.1Reactive follicular hyperplasia (Kimura dis.)10.1Schwannoma284.4Synovial chondromatosis50.7Synovial cyst60.9Villonodular synovitis487.5Xantoma10.1Table 4Malignant soft tissue tumors.Table 4NumberPercentageAngiosarcoma20.6Clear cell sarcoma30.9Dermatofibrosarcoma protuberans30.9Epitheloid sarcoma30.9Extraskeletal chondrosarcoma72.1Extraskeletal Ewing\'s sarcoma113.3Extraskeletal osteosarcoma72.1Fibrosarcoma41.2Histiocytic sarcoma10.3Kaposi sarcoma10.3Leiomyosarcoma134.0Lymphoma154.6Liposarcoma5516.9Malignant mesenchymal tumor4513.8Malignant melanoma92.7Malignant peripheral nerve sheath tumor226.7Plasmacytoma (soft tissue)10.3Pleomorphic sarcoma3510.7Rhabdomyosarcoma164.9Spindle cell sarcoma30.9Squamous cell carcinoma154.6Synovial sarcoma5316.3Table 5Metastatic tumors.Table 5NumberPercentageBreast5918.3Bladder103.1Endometrium41.2Gastrointestinal144.3Kidney4814.9Lungs5717.7Lymphoma20.6Medulloblastoma10.3Mesothelioma10.3Neuroendocrine tumor20.6Over20.6Pancreas30.9Primer unknown8927.7Prostate154.6Thyroid123.7Urinary system20.6Table 6Non-tumor causes.Table 6NumberPercentageBursitis223.2Callus tissue152.2Dystrophic calcification10.1Fat necrosis121.7Gout tofus60.8Hematoma30.4Hydatid cyst60.8Inflammatory changes30.4Inflammatory event15522.8Inflammatory pseudotumor10.1Lymphadenitis20.2Metabolic disease20.2Myositis40.5Myositis ossificans91.3Nodular fasciitis60.8Normal tissue11617.1Osteoarthritis71.0Osteochondritis dissecans20.2Osteomyelitis649.4Osteonecrosis182.6Other7911.6Paget\'s disease40.5Synovial hypertrophy162.3Synovitis12117.8Tuberculosis40.5Table 7Placement of bone tumors.Table 7NumberPercentageClavicle181.5Femur diaphysis292.5Femur distal24621.2Femur proximal13111.3Fibula685.8Foot - ankle544.6Hand -wrist463.9Humerus17815.4Pelvic bones927.9Radius211.8Scapula292.5Tibia diaphysis161.3Tibia distal403.4Tibia proksimal14612.3Ulna151.2Vertebra262.2Table 8Placement of soft tissue tumors.Table 8NumberPercentageAnkle343.5Arm586.0Cruris828.5Elbow293.0Foot798.2Forearm495.1Hand13013.5Hip434.4Inginal60.6Knee9910.3Pelvis40.4Shoulder485.0Thigh25026.0Vertebral region30.3Wrist515.3Table 9Placement of metastatic tumors.Table 9NumberPercentageClavicle41.2Cruris10.3Femur diaphysis82.4Femur distal206.2Femur proximal12137.6Fibula distal10.3Fibula proximal20.6Foot20.6Forearm-radius41.2Gluteal20.6Hand415.5Humerus diaphysis51.5Humerus distal51.5Humerus proximal5015.5Knee10.3Pelvis4514.0Scapula92.8Shoulder72.1Scapula92.8Thigh92.8Tibia92.8Vertebral region123.7Table 10Location of non-tumoral causes.Table 10NumberPercentageAnkle101.4Arm131.9Clavicle91.3Cruris142.0Elbow243.5Femur12418.2Fibula81.1Foot446.4Forearm60.8Hand273.9Hip162.3Humerus405.8Knee14921.9Pelvis476.9Radius50.7Scapula40.5Shoulder81.1Thigh436.3Tibia608.8Ulna40.5Vertebral region172.4Wrist60.8Fig. 1Age distribution of bone tumors (horizontal column: ages, vertical column: numbers).Fig. 1Fig. 2Age distribution of soft tissue tumors (horizontal column: ages, vertical column: numbers).Fig. 2Fig. 3Age distribution of metastatic tumors (horizontal column: ages, vertical column: numbers).Fig. 3

All statistical analyses were performed using SPSS 22.0 statistical software (SPSS, Chicaco, IL, USA). Descriptive statistics are expressed as mean, frequency and percentage.

Results {#sec2}
=======

In histopathological examination of the 3133 patients, 2464 were diagnosed with tumor. Of all patients, 1146 (46.5%) were female and 1318 (53.5%) were male.

Of the tumoral lesions, 1496 (47,7%) were localized in the low extremity involving hips and distal, 771 (24,6%) in the upper extremity with shoulder joint and distal, 154 (4,9%) in the pelvic region and pelvic bones, and 43 (1,4%) in the thoraco-lumbar-sacral region and its bones.

Of all cases, 1178 (37,5%) were primary bone tumors, 965 (30,8%) primary soft tissue tumors, and 321 (10,2%) metastasis. Whereas 669 (21,3%) cases had non-tumoral causes. Excluding the non-tumoral causes, 1282 (52%) of bone and soft tissue tumors were benign and 1182 (48%) were malignant.

Bone tumors {#sec2.1}
-----------

The mean age was found as 28.7 years in 1182 patients with primary bone tumors. Of these cases, 662 (58%) were seen in males and 477 (42%) in females. The tumors were localized in lower extremity in 714, upper extremity in 307, pelvis in 92, and vertebral region in 26 patients.

The mean age was found as 26.5 and 31.1 in patients with benign and malignant tumors; respectively.

Benign bone tumors {#sec2.2}
------------------

Of the primary benign bone tumors, 194 (30,3%) were localized in the femur, 109 (17,0%) in the humerus, and 98 (15,3%) in the tibia ([Table 7](#tbl7){ref-type="table"}).

The mean age of the patients with osteochondroma, which was the most common benign bone tumor was found 24.1 (6--69) years. The most common localizations were femur distal (38, 29%), tibia proximal (16, 12%) and humerus proximal (15, 11%); respectively.

Malignant bone tumors {#sec2.3}
---------------------

Of the primary malignant bone tumors, 214 (x%) were localized in the femur, 86 (x%) in the tibia, and 69 (x%) in the humerus ([Table 7](#tbl7){ref-type="table"}).

The mean age of the patients with osteosarcoma, which was the most common primary malignant bone tumor was found 22.4 (6--79) years. The most common localizations were femur distal (109, 45%), tibia proximal (48, 19%), and humerus proximal (19, 7%), respectively.

Soft tissue tumors {#sec2.4}
------------------

The mean age of 965 patients with primary soft tissue tumors was 40.7 years. Of these cases, 453 (47%) were seen in male and 512 (53%) were seen in female patients. The tumors were localized in the lower extremity in 606 (60,3%), in the upper extremity in 376 (37,4%), in the pelvis in 17 (1,6%), and in the vertebral region (0,5%) in 5 patients.

The mean age was found as 38.0 (1--86) and 45.3 (2--87) years in patients with benign and malignant soft tissue tumors; respectively.

Benign soft tissue tumors {#sec2.5}
-------------------------

Of the primary benign soft tissue tumors, 171 (27,0%) were localized in the hand-wrist, 101 (15,9%) in the thigh, and 89 (14,0%) in the foot-ankle ([Table 8](#tbl8){ref-type="table"}).

The mean age of patients with lipoma, which was the most common benign soft tissue tumor was found as 44.5 (1--81) years. The most common localizations were thigh (32, 22,6%), shoulder (23, 16,3%), and arm (22, 15,6%).

Malignant soft tissue tumors {#sec2.6}
----------------------------

Of the primary malignant soft tissue tumors, 149 (45,9%) were localized in the thigh, 39 (12,0%) in the cruris, and 24 (7,4%) in the foot-ankle ([Table 8](#tbl8){ref-type="table"}).

The mean age of patients with liposarcoma, which was the most common malignant soft tissue tumor was found as 51.4 (24--80) years. The most common localizations were the thigh (33, x%), gluteal (6, x%), and cruris (5, x%).

Metastases and non-tumoral causes {#sec2.7}
---------------------------------

The mean age of 321 patients with metastatic disease was found as 57.4 (4--85). Of these cases, 187 were seen in male and 134 in female patients.

Of the metastatic tumors, 59 (18,3%) were originated from the breast, and 57 (17,7%) from the lung, while the primary of 89 (27,7%) tumors was unknown ([Table 5](#tbl5){ref-type="table"}).

The mean age of 677 patients with non-tumoral causes was found as 44,4 (1--96) years. Of these cases, 327 were seen in male and 351 in female patients.

Discussion {#sec3}
==========

Understanding the region specific age, gender, localization and incidence of tumors is helpful for the diagnosis, and the distribution of these tumors may differ. Therefore, it is necessary to know the distribution and features of bone and soft tissue tumors in Turkey.

Although activities on cancer registry have become concentrated in Turkey recently, there is no sufficient resource including a large series that show the incidence and diagnostic distribution of bone and soft tissue tumors.[@bib3]

There are many regional epidemiological study records in the literature.[@bib4], [@bib5] There are limited studies from Turkey to demonstrate the distribution of musculoskeletal system tumors. Whereas some of these studies include local hospital data,[@bib6], [@bib7], [@bib8] the others are in form of the analysis of the cases evaluated in tumor councils.[@bib9] In addition, there are also studies of more specific patient groups such as childhood tumors and bone tumors, vs.[@bib10], [@bib11], [@bib12]

In 1993, Gür et al published 11-year data of Ankara Gülhane Hospital including 420 cases, and reported that all data were consistent with the classical literature information and no any regional difference was found.[@bib6] In 2000, Kösem et al reported 6-year data of bone and soft tissue tumors of 250 from the region of Van.[@bib7] Differently, they reported that unlike obvious predominance of the lower extremity in the classical information, they found an equal distribution in the localization of soft tissue tumors.

In 2005, Solakoğlu et al published their 10-year data about age, gender and tumor localization of 937 cases with only bone tumors, and unlike classical literature they found giant cell tumor as the most common bone tumor in adults. Whereas Güngör et al published evaluation of 200 cases with only childhood benign tumors in 2008.[@bib10], [@bib11]

In 2011, Yücetürk et al published 20-year data of the Ege University musculoskeletal tumor council including 5658 cases.[@bib9] In that study, malignant musculoskeletal tumors accounted for 40% of all tumors. The authors reported that these high data were not resulted from the high regional incidence of these tumors, and was caused by the was resulted from the University tumor council being one of the limited reference centers. In our study, the ratio of malignant tumors was found even higher and was 48%. We attributed this high incidence to that our study did not include the population of benign tumors, which were radiologically diagnosed and followed-up with non-surgical methods, and to the gradually increased number of centers where benign tumors are followed-up and treated.

In 2014, Dabak et al published 25-year data of bone and soft tissue tumors from the central Blacksea region which contained 1925 cases.[@bib8] The authors reported that, soft tissue tumors were more common among women, and the ages with the benign and malignant soft tissue tumors encountered were 10 years older than the literature, and that the most common localization of soft tissue tumors was the wirst. In addition, since their study included only the cases that they performed surgery, the tumors which treatment is often non-surgical were less frequent. Similarly to the literature, in our study the most common localization of soft tissue tumors was found as the thigh.

In the study by Sevimli in 2017 which examined musculoskeletal tumors in Malatya province and surrounding (6 year, 710 cases), the most common malignant bone tumor was found as chondrosarcoma.[@bib13] Whereas in the present study, the most common malignant bone tumor was osteosarcoma, consistently with the literature.[@bib4], [@bib5], [@bib7], [@bib9], [@bib11]

The most common benign bone tumors are osteochondromes and the most common location was proximal humerus and around the knee.[@bib1] In our study, as well as many other studies, was consistent with this. Differently, Solakoglu et al found that osteochondroma was the most common tumor in children, giant cell tumor was the most common tumor in adults; Yucetürk et al found that the enchondroma was the most common tumor.[@bib6], [@bib8], [@bib11], [@bib14] Actually, it is known that the number of osteochondromas ocur much more from indicated, whereas due to require less operation, osteochondromas were seen less in studies.[@bib1], [@bib14]

Whereas the most common soft tissue sarcomas have been reported as pleomorphic sarcoma and liposarcoma, in our study the most common tumors were found as liposarcoma, synovial sarcoma and malign mesenchymal tumor. Pleomorphic sarcoma ranked four. We think that this difference was resulted from the lack of a subclassification in patients with the pathological outcome of malignant mesenchymal tumor.

In our study, the most common localizations of metastasis were found as the femur proximal, humerus proximal, and pelvis. Although the most common localization of metastasis has been reported as the vertebra in the literature, less common incidence of this region in our study could be explained by that these patients can be treated in orthopedics and neurosurgery clinics of our hospital, and this study included only the orthopedics archive and that most vertebral metastases could be treated with non-operative methods.

When the relationship between tumoral diseases and age is examined; both benign and malignant bone tumors are most commonly seen between 11 and 20 years of age, and our results are consistent with this information ([Fig. 1](#fig1){ref-type="fig"}). For soft tissue tumors, a narrow age range with an evidently high incidence of tumors can not be said as in bone tumors.[@bib8], [@bib10], [@bib15] It can be said that, in our study benign soft tissue tumors were more common in 11--60 age range, and malignant soft tissue tumors in 21--60 age range ([Fig. 2](#fig2){ref-type="fig"}). In their study, Dabak et al found the most common age range of metastatis tumors as 51--60 years. In our study the most common age range was found as 61--70 years followed by 51--60 years with a little difference ([Fig. 3](#fig3){ref-type="fig"}).

Similar to other studies, bone tumors were more common in male patients (58%), while soft tissue tumors were more common in female patients (53%).[@bib8], [@bib10] However, there are studies reported a higher incidence of soft tissue tumors among men in Turkey.[@bib9], [@bib12]

The most common metastatic bone tumors are originated from the breast and prostate followed by lungs, kidneys and thyroid.[@bib16] In our study, and in the study by Dabak et al the most common diagnoses were the tumors with unknown primary, and breast and lung localized tumors. The possible reason for lower incidence of prostate ca metastasis in these studies is that, the mentioned studies included the patients who underwent operation and prostate ca requires less surgery due to blastic metastases.

In conclusion; musculoskeletal tumors are rare, but descriptive data in any region are important in order to reduce mortality and improve treatment. No significant difference was found between the data of our hospital regarding epidemiology of the musculoskeletal system tumors and those from the other regions around the world. Further multicenter studies are needed in order to reach the information, which better reflects the demographics of musculoskeletal tumors in Turkey.
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